Quidel to Hold First Quarter 2013 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
testuser
Quidel to Hold First Quarter 2013 Financial Results Conference Call on April 23, 2013

SAN DIEGO, CA--(Marketwired - Apr 10, 2013) - Quidel Corporation ( NASDAQ : QDEL ), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic solutions, will release first quarter 2013 financial results after market close on Tuesday, April 23, 2013.

Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the results and answer questions. During the conference call, the company will also discuss business and financial developments and trends. The company's statements may contain or constitute material information that has not been previously disclosed.

To participate in the live call by telephone from the U.S., dial 866-515-2913 , or from outside the U.S. dial 617-399-5127 , and enter the pass code 64054813.

A live webcast of the call can be accessed at http://www.quidel.com , and the Web site replay will be available for 14 days. The telephone replay will be available for 48 hours beginning at 7:00 p.m. Eastern Time (4:00 p.m. Pacific Time) on April 23 by dialing 888-286-8010 from the U.S., or 617-801-6888 for international callers, and entering pass code 61483202.

About Quidel Corporation

Quidel Corporation serves to enhance the health and well being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Marketed under the QuickVue®, D3® Direct Detection and Thyretain® leading brand names, as well as under the new Sofia® and AmpliVue® brands, Quidel's products aid in the detection and diagnosis of many critical diseases and conditions, including, among others, influenza , respiratory syncytial virus , Strep A, herpes, pregnancy, thyroid disease and fecal occult blood . Quidel's research and development engine is also developing a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests to further improve the quality of healthcare in physicians' offices and hospital and reference laboratories. For more information about Quidel's comprehensive product portfolio, visit www.quidel.com and Diagnostic Hybrids at www.dhiusa.com .

Quidel Contact: Quidel Corporation Randy Steward Chief Financial Officer (858) 552-7931 Media and Investors Contact: Quidel Corporation Ruben Argueta (858) 646-8023 Email Contact

Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Smart Banner Choices: Decisions Beyond Design

Updated Category News Views 152

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 37

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 146

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 96

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 58

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 72

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 76

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 58

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading

Top 5 Most Recently Viewed Articles

Diane Nussbaum Celebrated as Pinnacle Professional Leader

Updated Category News Views 241

Diane Nussbaum Recognized for Excellence in Culinary Arts The Inner Circle proudly acknowledges Diane Nussbaum as a distinguished member in the ranks of Pinnacle Professionals. Her recent recognition underscores her invaluable contributions to the culinary world, especially in pastry arts and community engagement. Celebrating Achievements in Pastry Diane Nussbaum's career...

Continue Reading
Innovative Immunotherapy Approach Targeting Gastric Cancer Unveiled

Updated Category News Views 64

New Insights into Immunotherapy for Gastric Cancer ImmPACT Bio, a pioneering clinical-stage biopharmaceutical company, is making significant strides in cancer treatment with its innovative IMPT-601 therapy. This groundbreaking approach focuses on Claudin18.2 and TGF-? bispecific CAR T-cell therapy, aiming to redefine how we tackle gastric cancer. Understanding IMPT-601...

Continue Reading
ASML Holding's P/E Ratio Analysis: Understanding its Value

Updated Category News Views 322

Insights into ASML Holding's P/E Ratio In today's market, the share price of ASML Holding Inc. (NASDAQ: ASML) stands at $987.03, reflecting a rise of 2.12%. Although the stock experienced a decline of 6.22% over the last month, it has seen a significant surge of 46.89% over the past year. Investors might wonder about the stock's valuation, especially in light of the...

Continue Reading
Recent Insider Sales Raise Questions for Tetra Tech Stakeholders

Updated Category News Views 67

Recent Insider Activity at Tetra Tech Kirsten M Volpi, a notable Board Member at Tetra Tech (NASDAQ: TTEK), recently made headlines with an insider sale. She sold 1,950 shares, which totaled around $89,700. This transaction was reported in a Form 4 filing with the SEC, sparking interest among investors keen on such activities. Understanding Insider Transactions Insider...

Continue Reading
Cabaletta Bio's Short Interest Surge: What Investors Need to Know

Updated Category News Views 112

Understanding Cabaletta Bio's Recent Short Interest Trends Cabaletta Bio has seen a noticeable increase in its short percent of float, rising by a significant 38.24% since the previous report. Currently, the company has reported that there are a staggering 6.22 million shares sold short, which represents about 13.16% of all regular shares available for trading. This high...

Continue Reading